A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
Abroad (travel likely)RecruitingPHASE1
Conditions
Lung Cancer · Esophageal Cancer · Cervical Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of University of Science and Technology of China, Hefei, British Columbia, China